Loading...
You are here:  Home  >  Health  >  Current News

Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy



SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.


Other News

Trump administration backs looser Obamacare waivers for states NEW YORK (Reuters) - The Trump administration told states on Monday that it was opening the door for them to make changes to their health insurance ...
No silver lining in failed Bristol cancer drug trial COPENHAGEN (Reuters) - Bristol-Myers Squibb disappointed investors on Sunday as researchers detailed data for its Opdivo cancer immunotherapy, which...
Sanofi nears deal to sell some over-the-counter drugs to Ipsen: Bloomberg (Reuters) - Drugmaker Sanofi is close to selling some over-the-counter products to Ipsen SA , in a deal that could be valued at nearly 100 million ...

Found news:

Loading...

You might also like...

Bayer, J&J win third U.S. trial over Xarelto bleeding risk

Read More →